| Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States … DA Siegel MMWR. Morbidity and mortality weekly report 68, 2019 | 296 | 2019 |
| Pulmonary lipid-laden macrophages and vaping SD Maddock, MM Cirulis, SJ Callahan, LM Keenan, CS Pirozzi, ... New England Journal of Medicine 381 (15), 1488-1489, 2019 | 257 | 2019 |
| Update: interim guidance for health care providers for managing patients with suspected e-cigarette, or vaping, product use–associated lung injury—United States, November 2019 TC Jatlaoui MMWR. Morbidity and Mortality Weekly Report 68, 2019 | 110 | 2019 |
| E-cigarette use, or vaping, practices and characteristics among persons with associated lung injury—Utah, April–October 2019 N Lewis MMWR. Morbidity and mortality weekly report 68, 2019 | 78 | 2019 |
| Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the CleanUP-IPF randomized clinical trial FJ Martinez, E Yow, KR Flaherty, LD Snyder, MT Durheim, SR Wisniewski, ... Jama 325 (18), 1841-1851, 2021 | 63 | 2021 |
| Clinical, bronchoscopic, and imaging findings of e-cigarette, or vaping, product use–associated lung injury among patients treated at an academic medical center SK Aberegg, MM Cirulis, SD Maddock, A Freeman, LM Keenan, ... JAMA Network Open 3 (11), e2019176-e2019176, 2020 | 63 | 2020 |
| Update: interim guidance for health care professionals evaluating and caring for patients with suspected E-cigarette, or vaping, product use–associated lung injury and for … ME Evans MMWR. Morbidity and Mortality Weekly Report 68, 2020 | 56 | 2020 |
| Diagnosing EVALI in the time of COVID-19 SJ Callahan, D Harris, DS Collingridge, DW Guidry, NC Dean, MJ Lanspa, ... Chest 158 (5), 2034, 2020 | 45 | 2020 |
| E-cigarette or vaping product use–associated lung injury: Developing a research agenda. An NIH workshop report LE Crotty Alexander, LB Ware, CS Calfee, SJ Callahan, T Eissenberg, ... American journal of respiratory and critical care medicine 202 (6), 795-802, 2020 | 40 | 2020 |
| Probing changes in lung physiology in COPD using CT, perfusion MRI, and hyperpolarized xenon-129 MRI K Qing, NJ Tustison, JP Mugler III, JF Mata, Z Lin, L Zhao, D Wang, ... Academic radiology 26 (3), 326-334, 2019 | 27 | 2019 |
| Diagnosis of EVALI: general approach and the role of bronchoscopy SK Aberegg, SD Maddock, DP Blagev, SJ Callahan Chest 158 (2), 820-827, 2020 | 24 | 2020 |
| Validation of claims-based algorithms for pulmonary arterial hypertension R Papani, G Sharma, A Agarwal, SJ Callahan, WJ Chan, YF Kuo, ... Pulmonary Circulation 8 (2), 2045894018759246, 2018 | 24 | 2018 |
| Assessment of symptom, disability, and financial trajectories in patients hospitalized for COVID-19 at 6 months AJ Admon, TJ Iwashyna, LA Kamphuis, SJ Gundel, SK Sahetya, ID Peltan, ... JAMA network open 6 (2), e2255795-e2255795, 2023 | 20 | 2023 |
| Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized clinical trials WH Self, MS Shotwell, KW Gibbs, M De Wit, DC Files, M Harkins, ... Jama 329 (14), 1170-1182, 2023 | 18 | 2023 |
| NIH workshop report: e-cigarette or vaping product use associated lung injury (EVALI): developing a research agenda LE Crotty Alexander, LB Ware, CS Calfee, SJ Callahan, T Eissenberg, ... | 16 | 2020 |
| Pulmonary and critical care considerations for e-cigarette, or vaping, product use-associated lung injury D Hayes Jr, A Board, CS Calfee, S Ellington, LA Pollack, H Kathuria, ... Chest 162 (1), 256-264, 2022 | 14 | 2022 |
| Prospectively Assessed Long-Term Outcomes of Patients with E-Cigarette–or Vaping-associated Lung Injury DP Blagev, SJ Callahan, D Harris, DS Collingridge, RO Hopkins, JR Eve, ... Annals of the American Thoracic Society 19 (11), 1892-1899, 2022 | 10 | 2022 |
| Sporadic obliterative bronchiolitis: case series and systematic review of the literature SJ Callahan, A Vranic, L Flors, M Hanley, MH Stoler, B Mehrad Mayo Clinic Proceedings: Innovations, Quality & Outcomes 3 (1), 86-93, 2019 | 10 | 2019 |
| Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis SJ Callahan, M Xia, S Murray, KR Flaherty Respiratory medicine 119, 96-101, 2016 | 6 | 2016 |
| Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial SM Brown, CE Barkauskas, B Grund, S Sharma, AN Phillips, L Leither, ... The Lancet Respiratory Medicine 11 (9), 791-803, 2023 | 5 | 2023 |
